EVAg

Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the E gene, for 100 Rxns (Target designed by Charité Universitätsmedizin Berlin ; https://www.who.int/docs/default-source/coronaviruse/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf). The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf. For RUO (Research Use Only)

IF-slides to detect anti-nCoV antibodies by Immunofluorescence assay. The slides were prepared by infecting Vero cells with the first Swedish SARS-CoV-2 isolate (SARS-CoV-2/01/human/2020/SWE). The virus is fully sequenced (Genebank accession: MT093571). The slides are fixated in acetone, air-dried and preserved at -80°C. IF-analysis tested positive with SARS-CoV-2 infected human sera.

anti-GP 3 of Porcine reproductive and respiratory syndrome virus (PRRSV) murine monoclonal antibody, clone Hy P10-c40-c1 (CCLV-RIE 1167)

anti-N of Porcine reproductive and respiratory syndrome virus (PRRSV) murine monoclonal antibody, clone Hy P10-a1-10-c19 (CCLV-RIE 1168)

anti-GP 5 of Porcine reproductive and respiratory syndrome virus (PRRSV) strain I10, Hy P10-b38-c16 (CCLV-RIE 1089)

anti-GP 5 of Porcine reproductive and respiratory syndrome virus (PRRSV) strain I10 murine monoclonal antibody, clone Hy P10-a46-15 (CCLV-RIE 1175)

anti-GP 4 of Porcine reproductive and respiratory syndrome virus (PRRSV) murine monoclonal antibody, clone Hy P11.B2-b17 (CCLV-RIE 0375)

In this 2-day course the basic principles of routine virus neutralization and ELISA assays will be addressed by a combination of lectures, demonstration and hands-on training. Special attention will be given to quality control and assay validation. Topics include: cell culture, biosafety procedures, preparation of sera and virus stocks, ELISA and microarray formats, different virus neutralization tests using pseudotyped viruses and wildtype viruses, immunofluorescence staining of cells, calculation of titers, assay validation and quality control.

Anti-Middle East respiratory syndrome-related coronavirus NP protein polyclonal rabbit sera

Trans-national access (TNA) to a PD50 potency test for FMDV

Hybridoma cell culture supernatant containing anti-FMDVV antibodies; targeted antigen: 3A; clone: 8H8a; immunization antigen: recombinant non-structural protein 3ABC

Hybridoma cell culture supernatant containing anti-FMDVV antibodies; targeted antigen: 3B or C; clone: 9F2; immunization antigen: recombinant non-structural protein 3ABC

Hybridoma cell culture supernatant containing anti-PEDV antibodies; targeted antigen: spike protein; clone: 4H4B1; immunization antigen: PEDV strain "CV777"; IgG subtype: IgG2a

Hybridoma cell culture supernatant containing anti-PEDV antibodies; targeted antigen: matrix protein; clone: 2C3B2 ; immunization antigen: PEDV strain "CV777"; IgG subtype: IgG2b

Hybridoma cell culture supernatant containing anti-PEDV antibodies; targeted antigen: NP; clone: 1B6A3 ; immunization antigen: PEDV strain "CV777"; IgG subtype: IgG2b

Hybridoma cell culture supernatant containing anti-Teschovirus A / Porcine teschovirus (PTV4) antibodies; targeted antigen: unknown; clone: 2A9; immunization antigen: inactivated strain "1624/89"

Hybridoma cell culture supernatant containing anti-RHDV 1 antibodies; targeted antigen: unknown; clone: 30H12; immunization antigen: inactivated strain "Triptis"

Hybridoma cell culture supernatant containing anti-Teschovirus A / Porcine teschovirus (PTV5) antibodies; targeted antigen: unknown; clone: 33B9; immunization antigen: inactivated strain "F26"

Hybridoma cell culture supernatant containing anti-Equine torovirus antibodies; targeted antigen: unknown; clone: 8G4; immunization antigen: inactivated RVB 475 "Berne virus"

Hybridoma cell culture supernatant containing anti-Teschovirus A / Porcine teschovirus (PTV6) antibodies; targeted antigen: unknown; clone: 14B2; immunization antigen: inactivated strain "PS37"

Hybridoma cell culture supernatant containing anti-Enterovirus G / Porcine enterovirus B (PEV-9) antibodies; targeted antigen: unknown; clone: 3D9a; immunization antigen: inactivated strain "UKG 410/73"

Hybridoma cell culture supernatant containing anti-Teschovirus A / Porcine teschovirus (PTV7) antibodies; targeted antigen: unknown; clone: 35B7; immunization antigen: inactivated strain "F43"

Hybridoma cell culture supernatant containing anti-Enterovirus G / Porcine enterovirus B (PEV-10) antibodies; targeted antigen: unknown; clone: 8E5b; immunization antigen: inactivated strain "LP 54"

Hybridoma cell culture supernatant containing anti-Teschovirus A / Porcine teschovirus (PTV8) antibodies; targeted antigen: unknown; clone: 3F12; immunization antigen: inactivated strain "UKG 173/74"

Hybridoma cell culture supernatant containing anti-Sapelovirus A / Porcine sapelovirus antibodies; targeted antigen: unknown; clone: 6D3; immunization antigen: inactivated strain "V13"